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Objective: To assess the prevalence of headache subtypes in Gulf War Illness (GWI) and
Chronic Fatigue Syndrome (CFS) compared to controls.
Background: Approximately, 25% of the military personnel who served in the 1990–1991
Persian Gulf War have developed GWI. Symptoms of GWI and CFS have considerable
overlap, including headache complaints. Migraines are reported in CFS. The type and
prevalence of headaches in GWI have not been adequately assessed.
Methods: 50 GWI, 39 CFS and 45 controls had structured headache evaluations based
on the 2004 International Headache Society criteria. All subjects had history and physical
examinations, fatigue and symptom related questionnaires, measurements of systemic
hyperalgesia (dolorimetry), and assessments for exclusionary conditions.
Results: Migraines were detected in 64% of GWI (odds ratio = 11.6 [4.1–32.5]) (mean
[±95% CI]) and 82% of CFS subjects (odds ratio = 22.5 [7.8–64.8]) compared to only
13% of controls. There was a predominance of females in the CFS compared to GWI
and controls. However, migraine status was independent of gender in GWI and CFS
groups (x2 = 2.7; P = 0.101). Measures of fatigue, pain, and other ancillary criteria were
comparable between GWI and CFS subjects with and without headache.
Conclusion: The high prevalence of migraine in CFS was confirmed and extended to GWI
subjects. GWI and CFS may share dysfunctional central pathophysiological pathways that
contribute to migraine and subjective symptoms. The high migraine prevalence warrants
the inclusion of a structured headache evaluation in GWI and CFS subjects, and treatment
when present.
Keywords: migraine, gulf war illness, chronic fatigue syndrome, fibromyalgia, central sensitization, chronic pain,
fatigue, neurolimbic pathway
INTRODUCTION
Gulf War Illness (GWI), also known as Chronic Multisymptom
Illness (CMI), affects 25–30% of the 697,000 veterans deployed to
the 1990–1991 Persian Gulf War (Fukuda et al., 1998; Gray et al.,
2002; RAC-GWVI, 2008; Li et al., 2011). Veterans with GWI suffer
from a wide array of symptoms that include headaches, cognitive
dysfunction, chronic pain, fatigue, and other complaints (Fukuda
et al., 1998; Gray et al., 2002; Li et al., 2011). Gulf War veter-
ans often meet the criteria for chronic fatigue syndrome (CFS)
(Fukuda et al., 1994) and fibromyalgia (FM) strongly suggesting
overlap in symptoms for GWI and CFS (Wolfe et al., 1990; Peres
et al., 2002; Latremoliere and Woolf, 2009; Baraniuk and Zheng,
2010; Wolfe et al., 2010; Ravindran et al., 2011; de Tommaso et al.,
2011).
Headache is one of the eight ancillary criteria in the CFS
case definition (Fukuda et al., 1994; Baraniuk and Zheng,
2010; Ravindran et al., 2011). Complaints of headaches are also
reported in Gulf War veterans and over 50% of FM patients (Gray
et al., 2002; de Tommaso et al., 2011; Li et al., 2011). However,
the type and severity of headaches are not evaluated as a part of
the GWI, CFS, or FM case designation criteria (Wolfe et al., 1990;
Fukuda et al., 1994, 1998; RAC-GWVI, 2008; Wolfe et al., 2010;
Ravindran et al., 2011). We recently determined that migraines
are the primary type type of headaches in CFS (Ravindran et al.,
2011). Studies in FM have reported similar migraine predomi-
nance (de Tommaso et al., 2011). The exact relationships between
headache subtypes, fatigue, pain, hyperalgesia, and other systemic
complaints has been difficult to establish because of heteroge-
neous symptom presentation and/or lack of biomarkers that
identify a distinct pathophysiological process in GWI.
One mechanism that has been proposed to drive the com-
plaints of GWI and related illnesses is central sensitization
(Latremoliere and Woolf, 2009; Baraniuk and Zheng, 2010). This
process is defined as an amplification of responsiveness of cen-
tral pain-signaling neurons that clinicallymanifest as hyperalgesia
and/or allodynia (Latremoliere and Woolf, 2009). This normal
adaptive neuronal process is essential for learning, but has been
proposed to become dysregulated in each of these disorders and in
even in migraineurs (Gebhart, 2004; DaSilva et al., 2007; Tietjen
et al., 2009).
Neuroimaging studies report underlying dysfunction in
brain energetics, the brainstem, and thalamocortical tracts in
migraineurs (DaSilva et al., 2007). Alterations in these regions
may lead to the loss of descending anti-nociceptive processes
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coupled with changes in cerebrovascular dynamics. Specifically,
blood flow alterations in migraine headache are associated with
dysfunction in the trigeminovascular system, which innervate
cerebral blood vessels in the dura (Karatas et al., 2013). As a
result of trigeminal activation, migraineurs demonstrate hyper-
algesia, allodynia, and cognitive dysfunction during and between
episodes (Gebhart, 2004; DaSilva et al., 2007; Tietjen et al., 2009;
Baraniuk and Zheng, 2010; Karatas et al., 2013). These findings
may lend credence to the theory of central sensitization.
Similar patterns of gray and white matter abnormalities and
altered brain energetics in GWI, CFS, FM, and migraine suggest
that common central mechanisms may contribute to the type of
headaches and the cognitive impairments perceived as “brain fog”
(Lutz et al., 2008; Barnden et al., 2011; Puri et al., 2012; Rayhan
et al., 2013a,b). Understanding the pathophysiological mecha-
nisms underlying migraine may identify the primary dysfunction
that leads to the constellation of complaints in GWI, CFS, and
other overlapping disorders (Figure 1).
Although GWI patients complain of headache symptoms that
overlap with CFS, FM, and migraineurs, there is currently no
study that specifically assesses this in GWI. We hypothesized
that due to extensive symptom overlap, GWI subjects will have
similar rates of headache complaints subtypes. As a first step
toward testing this hypothesis, we focused on identifying clinical
FIGURE 1 | Central sensitization using migraine as a model. (1) Cortical
spreading depression (CSD) depolarizes cortical neurons and glia. (2) They
release glutamate, K+, H+, metalloproteases, and other agents that dilate
pial vessels and activate trigeminal nociceptive nerves. (3) The bifurcated
neurons release calcitonin gene related peptide (CGRP) and other
vasodilators near dural vessels by the axon response mechanism. Vascular
wall stretching activates additional trigeminal nociceptive neurons (4) that
have their primary synapse (5) in the upper cervical dorsal horn. (6)
Ascending secondary afferents activate the thalamus. (7) Other afferents
signal the periaqueductal gray matter. (8) Descending relays to the magnus
raphae nucleus activate descending serotonergic neurons to inhibit the
primary trigeminal (5 and 6) synapses. (9) Thalamocortical projections
stimulate the hypothalamus, somatosensory cortex, amygdala, limbic
system, and frontal cortex. (10) Pain, emotion, memory, frontal processing
and other inputs converge on the anterior cingulate gyrus (ACC) and (11)
interfere with its executive decision-making functions.
relationships between headache status, hyperalgesia (tenderness),
pain, and fatigue ratings in GWI. In addition, we compared such
complaints to CFS subjects and controls to further identify sim-
ilarities and/or differences between groups. The cross-sectional
design permitted estimation of the prevalences of headache, pain
and fatigue in GWI. Comparisons of GWI to CFS subjects allowed
validation and extension of previous findings. Migraine status,
GWI, CFS, FM co-morbidity and other conditions were diag-
nosed based on history and physical examination rather than
mail-in and/or online questionnaires. Detailed history and physi-
cal examination has proved to be highly reliable in previous stud-
ies (Ravindran et al., 2011). To supplement the research study,
we review the current literature into migraines and potential
mechanisms.
MATERIALS ANDMETHODS
SUBJECTS
GWI, CFS, and sedentary control subjects were recruited in 2 con-
secutive cohorts and combined for this analysis. Both cohorts had
populations of all three groups (GWI, CFS, and controls). Cohort
1 was recruited under Georgetown University Institutional
Review Board protocol #2006-481 (clinicaltrials.gov identifica-
tion number NCT00810329) between 2007 and 2009. Cohort 2
participated in a separate protocol between 2009 and 2011 that
was approved by the Georgetown University Institutional Review
Board (#2009-229; clinicaltrials.gov NCT01291758) and United
States Army Medical Research Materiel Command Human
Research Protection Office (USAMRMC HRPO #A-15547.0).
Approximately 400 GWI, CFS, and sedentary control subjects
responded to print and on-line advertising by contacting our
laboratory by telephone or e-mail. Each volunteer had an ini-
tial telephone screening during which they gave verbal consent.
Cohort 1 had 124 total eligible subjects identified after telephone
screening. Of the 124, 83 particpants completed the overall study.
Cohort 2 had 167 total eligible subjects identified after telephone
screening. Of the 167, 83 participants completed the overall study.
The 41 and 116 of the eligible participants from Cohort 1 and
2, respectively, who were identified to be eligible after telephone
screening o did not participate due to lack of response to follow-
up emails, phone calls, or did not show up to the scheduled clinic
visit.
Upon arrival in the Clinical Research Unit, all participants who
decided to complete the study reviewed and signed their informed
consent forms. All subjects had history and physical examinations
with scripted interviews to assess migraine, tension headache,
CMI, CFS, and FM criteria.
INCLUSION AND CASE DESIGNATION CRITERIA
Inclusion criteria for veterans included military service for at
least 30 days between August 1, 1990 and July 31, 1991. GWI
was designated using the 1998 Center for Disease Control
(CDC) criteria for CMI (Fukuda et al., 1998) with deploy-
ment for ≥30 consecutive days to the Persian Gulf War
region (RAC-GWVI, 2008). CMI criteria required >6 months
of complaints from at least two of the following categories:
(i) fatigue; (ii) musculoskeletal pain (muscle pain, joint pain,
stiffness of joints); and (iii) cognition and mood (feeling
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depressed, trouble remembering or focusing, mood changes, anx-
ious feelings, difficulty finding words, and difficulty sleeping)
(Fukuda et al., 1998).
CFS was defined by the 1994 CDC criteria (Fukuda et al.,
1994). Fatigue lasting >6 months with no medical, psychiatric,
or other attributable cause was required along with at least 4
of the 8 ancillary criteria: (i) cognitive problems with mem-
ory and concentrating, (ii) sore throat, (iii) sore lymph node
regions, (iv) myalgia, (v) arthralgia, (vi) headache with onset after
the fatigue, (vii) sleep disturbances with un-refreshing sleep, or
(viii) significant exacerbations of the severe fatigue and the other
symptoms immediately or as long as 24 h following exercise, cog-
nitive, or another activity that was more strenuous than usual.
All GWI subjects were also screened for CFS status during history
and physical examination to assess criteria overlap in conditions
(Fukuda et al., 1994).
To assess comorbidity in CFS and GWI, FM was also identi-
fied using the 1990 criteria (Wolfe et al., 1990) since the study
started before the 2010 criteria were introduced (Wolfe et al.,
2010). Subjects were assessed for widespread pain in 4 quadrants
above and below the waist, to the left and right of the midline
and involving the axial skeleton that had been present 3 months
and had no explanation. Manual thumb pressure of about 4 kg
was applied to 18 traditional tender points. FM required both
widespread pain and tenderness at ≥11 of 18 points (Wolfe et al.,
1990).
Migraine was defined by International Headache Society cri-
teria (Headache Classification Subcommittee of the International
Headache Society, 2004) using a structured interview to deter-
mine if a subject had ≥5 episodes lasting 4–72 h with at least
2 of (a) unilateral cephalgia, (b) pulsatile quality, (c) moderate
to severe pain severity, and (d) aggravation of the headache by
usual activities leading to disinclination to perform usual work
or other activities of daily living. Sensitivity to light or sound,
or nausea with or without emesis were required. Auras were
assessed for their prescient ability. For CFS diagnostic purposes,
migraines had to be of new onset coinciding with symptoms
of CFS, and so subjects with perimenstrual and progression of
headaches with childhood onset were excluded from considera-
tion. Information was collected about the duration of headaches
and will be discussed in an alternate manuscript.
Exclusion criteria included positive pregnancy test, lacta-
tion, active duty military personnel, claustrophobia, cardiovas-
cular restrictions, intolerance of needles, ferrous based implants,
major psychiatric illness, infectious status (e.g., HIV), neoplasm,
untreated endocrine and other chronic disease that may have
accounted for GWI or CFS associated symptoms (Reeves et al.,
2003, 2005; Sullivan et al., 2005; RAC-GWVI, 2008; Jones et al.,
2009).
QUESTIONNAIRES
Subjects from cohort 1 completed paper questionnaires. Subjects
from cohort 2 received a confidential website log-in identifier,
password and identification code so they could complete the
pre-study symptom and psychometric questionnaires using our
online confidential data collection procedure (Rayhan et al.,
2013c). No personal identifying information was collected using
either system. Locked facilities were under 24 h surveillance.
Workstations were only accessible by approved personnel and
protected by 128-bit encrypted password.
Subjects completed the CFS symptom severity questionnaire
to self-report their symptoms for the past 6 months (Baraniuk
et al., 2013). The severity of fatigue and the 8 ancillary symp-
toms was assessed using an anchored ordinal scale with 0 = no
complaint, 1 = trivial, 2 = mild, 3 = moderate, or 4 = severe
intensity. The scores of the 8 ancillary criteria were calculated and
the summed and are reported as “Sum8” (Baraniuk et al., 2013).
Subjective pain perceptions were quantified using the McGill
short form with its sensory, affective and total scores (Melzack,
1987) and relative disability and quality of life using the Medical
Outcomes Survey Short Form 36 (SF-36) (Ware and Sherbourne,
1995).
PROTOCOL
Hyperalgesia in FM has traditionally been ascertained by tender-
ness to manual thumb pressure of about 4 kg at ≥11 of 18 tender
points (Wolfe et al., 1990). We adapted this concept by pressing a
pressure strain gauge dolorimeter at a rate of 1 kg/s at the 18 sites
and over 5 paranasal sinus regions on all subjects (Naranch et al.,
2002; Rayhan et al., 2013a). Subjects were told that they were in
complete control of the pressure, and to report the point when
the pressure sensation switched to become painful. The mean of
the dolorimetry pressures has been previously used as a measure
of systemic and sinus hyperalgesia (Naranch et al., 2002; Rayhan
et al., 2013a).
STATISTICAL ANALYSIS
Data were tabulated in Microsoft Excel 2010 (Redmond,
Washington) for analysis with SPSS for Windows version 20
(IBM, Armonk, NY). Means were reported with [±95% confi-
dence intervals (CI)]. Significant differences in migraine status
and gender between the three groups were identified using the
2 × 3 Fisher’s exact probability test with the Freeman-Halton
extension and two-tailed P-values (Freeman and Halton, 1951).
Migraine headaches and CFS are more common in females than
males (Lea et al., 2004; Ravindran et al., 2011; Critchley and
Harrison, 2013). Due to this, gender was assessed as a controlled
comparison to test its influence on migraine headache and GWI
and/or CFS status. All variables were entered as dichotomous
values (0 or 1) and results from this analysis are reported with
continuity correction (Sweeting et al., 2004).
To protect against inflating the type 1 error rate, one way
multivariate analysis of variance (MANOVA) was used across all
15 non-dichotomous variables which included the ordinal rank-
ings in the CFS severity score, McGill total pain score and its
subscales, and the continuous scale systemic and sinus dolorime-
try values. This was followed by One-Way analysis of variance
(ANOVA) on each variable with post hoc testing using Tukey’s
Honest Significant Difference (HSD) test.
RESULTS
DEMOGRAPHICS
50 GWI, 39 CFS, and 45 control subjects were recruited. All of
the GWI subjects also met criteria for CFS. More than half of
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the GWI and control subjects were male, with a female predomi-
nance of 4:1 in CFS (P = 0.00001 by Fisher’s Exact test), with no
significant differences in age (Table 1).
HEADACHE STATUS
Migraines were detected in 64% of GWI (odds ratio = 11.6
[4.1–32.5]) and 82% of CFS (odds ratio = 22.5 [7.8–64.8]) sub-
jects compared to 13% of controls (P = 5.5 × 10−11; Table 2).
Migraines status was characterized with aura (MA) and with-
out aura (MO) with results showing the anticipated 3:1 ratio
(Table 2). Co-morbid migraine and tension headaches were fre-
quent. Tension headaches without a migraine diagnosis were
present in ∼20% of GWI, 7% of CFS, and 26% of control sub-
jects (Table 2). Gender did not influence CFS, GWI, andmigraine
status [χ2
(1, n= 89) = 2.69, P = 0.10].
During history and physical examinations, many patients
described that they had complained of having frequent to daily
headaches to their regular physicians. Despite this, new diagnoses
were made during the clinic visit in this protocol. This may sug-
gest under evaluation of migraines in the normal clinical setting.
Treatment was initiated in about half of the GWI and CFS sub-
jects. Subjects who developed migraines during their visit here
were given trials of sumatriptan. The drug was uniformly bene-
ficial lending additional support for migraine pathology. Results
specific to these findings are reported elsewhere.
MANOVA RESULTS
One-Way MANOVA confirmed the assumption that there would
be one or more significant differences between patient groups
(control, CFS, or GWI; independent variables) using the multi-
ple study outcomes [Pillai’s Trace = 0.904, F(26, 212) = 6.73, P =
1.5 × 10−16]. The multivariate effect size (partial eta squared)
was estimated at η2 = 0.452 which implies that 45.2% of the
variance in the dependent variable was accounted for by patient
grouping.
Table 1 | Demographics.
Controls (n = 45) CFS (n = 39) GWI (n = 50) P-value
Age 43.7 [39.9–47.5] 46.3 [43.1–49.5] 46.7 [44.3–49.1]
% Male 53.3% 20.5% 68.0% 0.00001*
*2 × 3 Fisher’s exact test; Mean [±95% CI].
Table 2 | Headache status.
Parameter Controls CFS GWI
(n = 45) (n = 39) (n = 50)
Migraine headache 6/45 (13.3%) 32/39 (82.1%) 32/50 (64%) 5.5 × 10−11*
With Aura (MA) 1/6 22/32 24/32
Without Aura (MO) 5/6 10/32 8/32
Comorbid migraine
and tension
headaches
3/6 24/32 20/32
Tension headache
alone
12/45 (26.6%) 3/39 (7.6%) 10/50 (20%)
∗2 × 3 Fisher’s exact test; Mean [±95% CI].
FIBROMYALGIA AND DOLORIMETRY
Systemic hyperalgesia was noted as widespread pain in 62% of
GWI and 70% of CFS subjects. Manual thumb-pressure caus-
ing pain at ≥11/18 tender points were more common in GWI
(64%) and CFS (89%) than controls (18%; P = 7.7 × 10−8 by
Fisher’s Exact test). FM was diagnosed in 38 and 56% of CFS
and GWI, respectively, compared to none of the control sub-
jects. Dolorimetry indicated that GWI and CFS had significantly
greater hyperalgesia over systemic regions [F(2, 128) = 18.8, P =
7.5 × 10−8; ANOVA followed by Tukey’s HSD test] and the 5
paranasal sinus regions [F(2, 128) = 15.5, P = 9.6 × 10−7] than
control groups (Table 3).
SELF-REPORTED COMPLAINTS
The CFS severity score results were equivalent for GWI and CFS,
and significantly greater than controls for fatigue, the 8 ancil-
lary criteria, and the Sum8 score [Figures 2, 3A; F(2, 128) > 14.6,
P < 1.8 × 10−6]. Sore throat and lymph nodes were the crite-
ria with the lowest average scores in GWI and CFS. Controls
had significantly lower total and subscale scores on the McGill
pain questionnaire compared to CFS and GWI subjects (Table 4;
F(2, 128) > 38.1, P < 1.2 × 10−13]. Controls also had higher SF-
36 domain scores compared to CFS and GWI subjects [Table 4;
F(2, 128) > 40.1, P < 1.2 × 10−19].
COMPARISON OF CFS AND GWI PATIENTSWITH ANDWITHOUT
MIGRAINE
Because there was no significant association between gender
and migraines, we combined the CFS and GWI cohorts to
compare groups with (n = 64) and without (n = 25) migraine
diagnosis. All self-reported and demographic variables were sim-
ilar. The Sum8 scores were also similar with the exception of
the ordinal headache rating, systemic and sinus pain thresh-
olds (Figures 3B–D). As expected, CFS and GWI subjects with
migraines had significantly higher headache ratings compared to
patients without migraines and controls [Figure 3B; F(2, 128) =
44.4, P = 2.2 × 10−15]. In addition, migraineurs had lower sys-
temic [Figure 3C; F(2, 128 ) = 20.9, P = 1.5 × 10−8] and sinus
pain thresholds [Figure 3D; F(2, 128) = 15.3, P = 1.1 × 10−6]
indicating tenderness and potentially central sensitization.
DISCUSSION
All of the GWI veterans recruited met CMI and CFS criteria
(Fukuda et al., 1994, 1998). Overlap in case designation criteria
is consistent with previous findings (Ravindran et al., 2011;
Rayhan et al., 2013a,b). Scores for self-reported questionnaires,
systemic and sinus pain thresholds, and migraine for GWI and
Table 3 | Systemic hyperalgesia.
Parameter Controls (n = 45) CFS (n = 39) GWI (n = 50)
Systemic dolorimetry (kg) 5.5 [4.7–6.3] 2.7 [2.2–3.0]* 3.5 [2.9–4.1]*
Sinus dolorimetry (kg) 2.2 [1.8–2.6] 0.96 [0.80–1.1]* 1.4 [1.2–1.7]*
GWI and CFS subjects had significantly lower systemic and sinus pain thresholds
compared to controls. ∗P < 0.0001 vs. controls, ANOVA followed by Tukey’s test;
mean [95% CI].
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FIGURE 2 | CFS symptom severity scores. The severity of fatigue and
the 8 ancillary criteria were scored on an anchored ordinal scales from
0 to 4. Controls (blue columns) had significantly lower scores for each
item compared to GWI (yellow columns) and CFS (red columns).
∗P < 0.0000018; ANOVA followed by Tukey’s HSD test; error bars depict
the mean [±95% CI].
CFS subjects were comparable. The high prevalence of migraine
in CFS was verified and extended to include GWI (Peres et al.,
2002; Ravindran et al., 2011). GWI had significantly lower SF-36
scores than controls indicating severe impairment of quality of
life (Buchwald et al., 1996). This indicates a large unmet need to
diagnose and treat migraine in GWI and CFS, and to expand the
options for therapy of these conditions.
GWI subjects tended to be male due to the higher ratio of
men in the military. In contrast, CFS and FM is predominantly
diagnosed in the civilian female population (Reiffenberger and
Amundson, 1996; Okifuji et al., 1999; Eisen et al., 2005; Stephen,
2005; RAC-GWVI, 2008; Li et al., 2011). The high prevalences
of migraine in GWI and CFS were independent of gender. This
finding may be the result of exclusion of menstrual and chronic
childhood onset migraine from our study population, but is also
consistent with the lack of association of migraine with estrogen,
progesterone and other sex hormone receptor polymorphisms
(Schürks et al., 2010).
The causes of GWI and CFS have been hotly contested with
little consensus. However, recent work suggests that toxic expo-
sures (sarin gas, pesticides, particulates from oil fires, etc.) and/or
acetylcholinesterase inhibitor use in the Persian Gulf may be tem-
porally associated with GWI onset (RAC-GWVI, 2008; Steele
et al., 2012). Diverse infectious and stressor triggers have been
proposed, but not proven, to underlie CFS and FM in the
civilian population (Wolfe et al., 1990; Fukuda et al., 1994;
Reiffenberger and Amundson, 1996; Peres et al., 2002; Ravindran
et al., 2011).
The seemingly confusing symptomatology of these disor-
ders requires a fresh, systems biology conceptual approach that
integrates systems involved in assessing afferent inputs, spinal
cord and brain processing, and the conscious perceptions that
are conveyed as subjective complaints. Sensory afferent infor-
mation from mucosal organs such as the nose (neurological
non-allergic rhinitis of CFS (Baraniuk et al., 2005), esophagus
(“nutcracker esophagus”), bowel (irritable bowel syndrome) (Lea
et al., 2004), bladder (irritable bladder syndrome and interstitial
cystitis) is poorly localized in the insular somatosensory cortex.
Interoceptive visceral sensations may enter the consciousness of
some subjects and be perceived as serious illnesses (Critchley and
Harrison, 2013). Chronic irritation, inflammation, or centrally
released mediators may lead to excessive glutamate release that
activates neuronal AMPA receptors to promote the transmission
of nociceptive messages (Rowbottom et al., 1998; Goadsby et al.,
2002; Fukui et al., 2008) The resulting perceptual state may be an
example of neural plasticity gone awry.
Dysregulation of neuropathic sensory relays to the dorsal pons
may lead to excessive pain and tenderness (hyperalgesia, allo-
dynia), fearful memories as in posttraumatic stress disorder,
impaired executive decision-making (“brain fog”), and char-
acteristic features of GWI and CFS. The synaptic molecular
changes lead to neural hypersensitivity and hyperresponsiveness
to extrinsic and central, intrinsic activation that is termed “central
sensitization” (Latremoliere and Woolf, 2009). A range of gene
polymorphisms such as ion channelopathies may modify the risk
for illnesses development in the population. For example, certain
variants of Panx1 ion channels may be dysfunctional and more
vulnerable to stressors that promote widespread neurotransmitter
release (Rowbottom et al., 1998; Goadsby et al., 2002; Fukui et al.,
2008). In a rat model of migraine, activation of Panx1 channels
on peripheral trigeminal neurons caused cerebrovascular dysreg-
ulation with changes suggestive of aura followed by headache
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FIGURE 3 | Sum8 and comparison between CFS and GWI subjects based
on migraine status. (A) Sum of 8 scores which total the 8 ancillary criteria
from the CFS severity score. (B) CFS and GWI subjects were combined to
show that migraineurs (n = 64) had higher ratings of headache severity (2.9
[2.7–3.2]) compared to CFS and GWI subjects with no migraines (2.1
[1.6–2.5]; n = 25) and controls (0.88 [0.51–1.3]; n = 45). (C) CFS and GWI
subjects with migraines had lower systemic pain thresholds (2.8 [2.4–3.2])
compared to those with no migraines (4.2 [3.4–5.1]) and controls (5.5
[1.6–2.5]). (D) CFS and GWI migraineurs had lower sinus pain thresholds (1.1
[0.9–1.3]) compared to CFS and GWI with no migraines (1.6 [1.3–1.9]) and
controls (2.2 [1.8–2.6]). ∗P ≤ 0.05; ANOVA followed by Tukey’s HSD test;
error bars depict the mean [±95% CI]. ∗∗P ≤ 0.001.
(Karatas et al., 2013). Evidence supporting central sensitization
has been found in each of these chronic nociceptive, interocep-
tive, and fatiguing illnesses (Malick and Burstein, 2000; Maizels
and Burchette, 2004; Meeus and Nijs, 2007).
Acute episodes of migraine and its consequences may provide
a model for central sensitization (Figure 1). The triggering event
may be an acute, extreme, and prolonged depolarization called
cortical spreading depression (CSD) (Pietrobon, 2005; Smith
et al., 2006; Eikermann-Haerter and Ayata, 2010). The molecular
and electrical events initiating CSD involve glial and neuron cell
body depolarization with an extreme efflux of K+ out of cells, and
influx of Na+ and Ca2+ (Smith et al., 2006; Ayata, 2010; Charles,
2010).
Returning the intracellular K+ concentration to the high level
required to repolarize these cells can take several minutes instead
of milliseconds. The prolonged depolarization leads to oligemia
that may cause transient hypoxia, depletion of oxygenated neu-
roglobin reserves, (Casado et al., 2005) and anaerobic glucose
metabolism with lactic acid production. Release of autoregula-
tory vasodilators leads to profound reactive cortical vessel dilation
and hyperemia. In animal models, the CSD spreads outwards in
concentric fashion at the rate of 3–5mm per minute as a wave of
intense depolarization with oligemia followed by autoregulatory
hyperemia. The change in blood flow can be detected by arterial
spin labeling using 3 Tesla fMRI (T2 weighted perfusion changes)
(Swartz and Kern, 2004). Peri-infarct depolarizations may be a
similar phenomena in strokes, brain trauma, and other head
injuries (Strong and Dardis, 2005; Fabricius et al., 2006; Strong
et al., 2007). CSD may be analogous to the chaotic, stochastic
cellular depolarization of atrial fibrillation, premature ventricular
contractions (PVC’s), esophageal spasm, or epilepsy.
Chronic CSD-like depolarization in migraine, GWI and CFS
may promote central sensitization and progressive dysfunction
of the anterior cingulate gyrus (ACC) and other neuroanatom-
ical loci (Jensen et al., 2009; Obermann et al., 2009), “Neural
plasticity” (Pietrobon, 2005) may reinforce conditioned mem-
ories and contribute to affective dysfunction, anxiety, fear and
posttraumatic stress disorder (PTSD), (Woodward et al., 2006)
fatigue, pain, hyperalgesia, allodynia and cognitive dysfunction
(“brain fog”) (Meeus and Nijs, 2007). Neurovascular dysfunction
may cause gray matter thinning and white matter abnormalities
(prevalence = 16–40%; OR = 3.9, 95% CI = 2.26–6.72) that
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Table 4 | McGill pain and SF-36 scores.
Parameter Controls (n = 45) CFS (n = 39) GWI (n = 50)
MCGILL SCORE
Sensory domain 5.2 [3.2–7.3] 13.9 [11.6–16.1]* 16.2 [11.8–20.6]*
Affective domain 1.0 [0.47–1.5] 4.1 [3.0–4.9]* 6.1 [5.2–7.0]*
Total score 6.2 [3.7–8.7] 17.8 [15.0–20.6]* 23.8 [21.2–26.4]*
MOS SF-36
Phys. Functioning 77.4 [62.9–91.8] 40.0 [33.2–46.8]* 43.9 [35.6–52.1]*
Role physical 70.6 [51.2–89.9] 7.1 [0.8–13.5]* 12.9 [5.1–20.6]*
Bodily pain 68.1 [53.7–82.5] 29.6 [23.9–35.3]* 28.5 [22.3–34.7]*
General health 67.7 [54.1–81.3] 34.7 [28.1–41.3]* 27.6 [22.4–32.9]*
Vitality 58.2 [45.7–70.7] 11.9 [7.9–15.7]* 16.3 [12.3–20.3]*
Social functioning 75.7 [61.1–90.4] 24.3 [17.9–30.7]* 25.0 [18.9–31.9]*
Role emotional 84.3 [69.4–99.3] 58.1 [43.1–73.1]* 30.5 [18.1–42.9]*
Mental health 75.3 [69.1–81.5] 64.7 [58.9–70.4]* 50.1 [42.3–57.3]*
GWI and CFS subjects self -reported significantly higher pain ratings on the McGill pain questionnaire. GWI and CFS subjects have significantly lower quality of life
scores compared to controls for the eight SF-36 domains indicating impairment. (* vs. controls, P < 0.0001; ANOVA followed by Tukey’s test; Mean [±95% CI]).
accentuate these disabilities (Burgmer et al., 2009; May, 2009;
Schwedt and Dodick, 2009).
Alternative central sensitization hypotheses of migraine such
as the “Unitary Hypothesis” suggest a primary role for cor-
tical and limbic structures (Burstein and Jakubowski, 2005).
Burstein and Jakubowski proposed that the well-known triggers
of migraine stimulated multiple hypothalamic, limbic, and cor-
tical nuclei that project axons to the superior salivatory nucleus
(SSN). The SSN is a preganglionic parasympathetic nucleus that
activates the postganglionic sphenopalatine ganglion. The release
of acetylcholine, vasoactive intestinal peptide (VIP), and nitric
oxide (NO) may initiate vasodilation of meningeal vessels. Wall
stretching would then stimulate mechanoceptors on trigeminal
afferent neurons that convey the signal of migraine neurovascular
pain.
Another alternative is the central periaqueductal gray matter
(PAG) hypothesis. The PAG has been considered a migraine gen-
erator. Positron emission tomography scans performed during
spontaneous migraine attacks found activation of the PAG, dor-
sal pons near the locus ceruleus, and ACC (Weill et al., 1995).
Activation of the ACC is not fully explained, but could indicate
interference with executive decision-making and other cogni-
tive functions (Rayhan et al., 2013a). Sumitriptan relieved the
migraine symptoms, but the PAG remained activated. This sug-
gested that the PAG may act as a “migraine generator” with the
latent potential to trigger additional attacks. Other lines of evi-
dence implicating the PAG in migraine include the correlation
between the duration of illness with iron deposition (a marker
of dysfunction) near the PAG, caudate and putamen (Aurora,
2009; Kruit et al., 2009). Dihydroergotamine binds to the PAG
and dorsal raphe nucleus, (Goadsby and Gundlach, 1991) while
naratriptan injection into the PAG has an antinociceptive effect
(Bartsch et al., 2004).
Dysregulated brain stem release of NO and calcitonin gene
related peptide (CGRP) may represent a molecular mechanism
to initiate migraine and facilitate central sensitization show in
Figure 1. These mediators may act synergistically (Panconesi
et al., 2009) to initiate: (i) inhibition of anti-nociceptive func-
tions; (ii) phantom, self-generated sensory phenomena that may
include pain, visual (e.g., photosensitivity (Recober et al., 2010)
auditory, and vestibular aberrations; (iii) retrograde activation
of trigeminal ganglion afferents leading to CGRP release from
branched nerve endings around dural and pial vessels (reverse
of 3–5 on Figure 1); (iv) unregulated nociceptive responses from
vascular stretch receptors (5 on Figure 1); and (v) facilitate the
other ascending nociceptive and cognitive dysfunction (7–11 on
Figure 1).
The “neurolimbic hypothesis” extends the role of the PAG
as a “migraine generator” to include activation of a proposed
neurolimbic pain network (Maizels et al., 2012). In this heuris-
tic, migraine represents that end result of dysfunctional brain
network activities, rather than the consequence of defects in indi-
vidual ion channels, other proteins, or anatomical nuclei. Maizels
et al. propose that brainstem pain-modulating circuits have bidi-
rectional connections with the limbic system (amygdala, insula,
ACC, orbito-frontal cortex, prefrontal cortex, hypothalamus) that
interact tonically to modulate migraine expression 974).
This hypothesis is based on the existence of a major net-
work of trigeminovascular - sensitive neurons that innervate
the thalamus, with thalamic relays to widespread regions of the
cortex (Noseda et al., 2011; Karatas et al., 2013). This path-
way originates in the trigeminal nerve endings in pial and dural
vessel walls. These primary trigeminal neurons innervate the
cell bodies of second-order trigeminovascular neurons that are
located in laminae I and V of the dorsal horn of the caudal
medulla and upper cervical C1 and C2 spinal segments. The
secondary ascending neurons have been traced electrophysiologi-
cally to themidbrain, where they bifurcate into an axon projecting
to thalamic posterior (Po), ventral posteromedial (VPM), and
parafascicular nuclei, and a second axonal limb that arborizes
and terminates in anterior, lateral, perifornical and posterior
hypothalamic nuclei, and lateral preoptic areas. The third-order
trigeminovascular—responsive thalamic neurons convey signals
to wide variety of cerebral regions. VPM and Po neurons have
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axons that bifurcate and issue dense terminal arborations in
the trigeminal barrel-field region of the primary somatosen-
sory cortex (S1BF) and secondary somatosensory cortex (S2).
Additional Po neurons project to extra-trigeminal regions of
S1, the primary auditory (AuD/Au1), retrosplenial (RSA), pari-
etal association (PtA), primary and secondary visual (V1/V2)
cortices, and primary and secondary motor cortices (M1/M2).
Neurons from the laterodorsal (LD) and lateroposterior (LP) tha-
lamic nucleus project to M1 and M2 regions, trigeminal and
extratrigeminal S1 regions, secondary visual cortex mediome-
dial (V2MM), and the ectorhinal cortex (Aurora, 2009; Burstein
et al., 2010; Noseda et al., 2011). This pathway connects the
primary meningeal nociceptive signals to the functionally dis-
tinct and anatomically remote cortical areas that are involved in
migraine—related dysregulation of affect, motor function, visual
and auditory perception, spatial orientation, memory retrieval,
olfaction, and allodynia (Burstein et al., 2010).
Resting state fMRI functional connectivity studies of interic-
tal migraine subjects provide additional support for abnormal
brainstem—limbic system interactions (Mainero et al., 2011).
Functional connectivity is the property of brain regions to
harmoniously signal to each other, and indicates their capability
to act in cooperative fashion. Migraineurs had increased
functional connectivity between the PAG and thalamus, posterior
parietal cortex, anterior insula, somatosensory cortex that are
involved in somatosensory, interoceptive, and nociceptive pro-
cessing. Those subjects with a high frequency of migraines
had increased connectivity between the PAG, anterior insula,
nucleus cuneiformis, and hypothalamus, but reduced connec-
tivity of PAG with the prefrontal cortex, ACC, amygdala, and
medial thalamus. Decreased connectivity between the PAG and
anterior and posterior cingulate cortex, hippocampus, putamen,
and posterior insula has been confirmed in a separate group
who had frequent migraines (Maleki et al., 2011a). Women had
more significantly reduced functional connectivity of the PAG to
the posterior cingulate cortex and amygdala than men (Maleki
et al., 2011b). Functional connectivity alterations were more
pronounced in adults than children (Lebel et al., 2011). When
allodynia was present, migraineurs had decreased connectivity
between the PAG, prefrontal cortex, ACC, and anterior insula.
Therefore, magnetic imaging studies in GWI and CFS should
take into account potential changes in baseline cerebrovascular
hemodynamic responses (Rayhan et al., 2013b), graymatter inter-
connectivity, and white matter integrity (Rayhan et al., 2013a).
Table 5 | Approach to patients with overlapping migraine, GWI, CFS, FM, and other disorders (adapted from Maizels et al., 2012).
Intervention Benefit
Clinical evaluation Evaluate personality style (e.g., perfectionism, caregiver), lifestyle factors (“pressure cooker”), life circumstances (e.g., an
abusive relationship), other stressors, coping skills, and psychiatric comorbidity that have a profoundly negative impact on
quality of life.
Patient education Limbic functions regulate mood, emotion, perceptions, and responses to stressors, personality, coping styles, and cognitive
function.
These have beneficial and detrimental effects on affect, fatigue and pain.
Depression and anxiety are important risk factors for migraine transformation (Lipton, 2009). Affective dysfunction should be
anticipated with this complex of unpredictable complaints and current unsatisfactory treatment options.
Physician education Conceptualizing these illnesses as dysfunctional pain, interoceptive, cognitive, and other brain networks is novel, and more
difficult to appreciate than a specific genetic, neurotransmitter, or brainstem nucleus problem.
This realization opens the way to diagnosis, lays a solid foundation for the patient–doctor relationship and expands the scope
of therapeutic options.
Treatment Although there is not as yet evidence to show that treating psychiatric comorbidity influences headache outcomes, it appears
clinically prudent to do so.
Non-pharmacologic treatments such as cognitive behavioral therapy, carefully prescribed activity levels, acupuncture, tai chi,
and other efforts to “retrain the brain” are often neglected aspects of treatment.
Combinations of low dose pharmaceutical, physical, cognitive, and other therapies are likely to be superior to single modalitie
(Holroyd et al., 2009, 2010).
Research Atypical responses to stressors will play a critical role in the identification of biomarkers, neuroimaging characteristics, future
diagnostic algorithms, pathophysiological mechanisms, and logical and beneficial treatments.
The impact of triptan drugs, topiramate, and other migraine therapies on GWI and CFS functional status has not been studied.
Limitations Identification of unrecognized exacerbating factors, inadequate non-pharmacologic treatment, and the presence of comorbid
conditions such as anxiety, pain, and migraine is an essential component of building a satisfactory healthful relationship
(Lipton et al., 2003).
Set attainable limits and goals for cognitive and physical activities, and expectations of benefits from current medical
treatments.
Regular follow-up can ensure treatment compliance and reinforce the security of on-going clinical care without the perception
of abandonment or rejection felt by many GWI and CFS patients.
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Disruption of these intricate neural pathwaysmay represent a new
paradigm for understanding complex neurological diseases.
These objective findings have important clinical implications
for the subjective presentation of migraine, GWI and CFS sub-
jects. A common presentation is:
“. . . a middle-aged woman with chronic migraine and medication
overuse, as well as fibromyalgia. In addition, there is anxiety and
depression, fatigue and insomnia, and the familiar exhaustive list
of psychotropics and antiepileptic drugs tried and failed” (Maizels
and Burchette, 2004).
This type of patient may seem exceedingly frustrating, since
many physicians find the panoply of symptoms daunting and
their armamentarium bare. The physician’s quandary can be
deepened as they investigate the history further. Regardless of
whether they consider themselves “lumpers” or “splitters,” the
presence of one functional syndrome increases the probability of
others (Bradley, 2008). The situation is all the more exasperat-
ing since current medical dogma does not provide a satisfactory
explanation for the underlying pathophysiology. Maizels et al.
(2012) provide a logical approach based on their neurolimbic
model, knowledge of the dysfunctional of serotonergic neural
pathways, and central nature of the nociceptive, interoceptive,
somatosensory, and fatigue complaints (Table 5).
This cross-sectional investigation had several limitations.
Although presence and absence of aura was identified, dur-
ing subgroup analysis of migraines subjects were not grouped
based upon the presence or absence of aura due to the small
sample size. It was not designed to correlate migraine phe-
notypes in GWI with triggers such as fasting, loss of sleep,
odors, hormonal changes, and stress (Fukui et al., 2008).
Longitudinal changes in migraine severity, systemic hyperalge-
sia, fatigue, and functional status await larger epidemiological
and treatment studies. Analysis of magnetic imaging correlates
are pending.
CONCLUSION
GWI and CFS subjects have a high prevalence of migraine
headaches, comparable patterns of systemic and cognitive
complaints, and share overlapping phenomenological case
designation criteria. CFS and GWI had lower systemic pain
thresholds indicating systemic hyperalgesia and central sensitiza-
tion. The loss of descending inhibitory antinociceptive aminergic
signals may contribute to spinal sensitization, but cannot explain
the many other cerebral, brainstem, and autonomic abnormal-
ities. It is tempting to speculate that the parallel findings of
GWI, CFS, and migraine indicate a shared underlying patho-
physiological mechanism of central nervous system neural path-
ways that may account for chronic pain, fatigue, and cognitive
dysfunction (“brain fog”). Interdisciplinary studies that address
these diverse components of illness are required to identify rel-
evant dysfunctional pathways and molecular mechanisms that
may lead to reductionist approaches for evaluation of future
drug treatments.
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